Absolutely. And the data seems to suggest starting Retts sufferers on Daybue earlier in life is better. So this could build considerably, just perhaps not as fast as some hoped. Either way if anyone is talking $40+ in the next year then that'll only be on the back of a takeover and no buyer will be as interested in Daybue as they are 2591.
Ann: Q2 2024 update, page-8
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.98 |
Change
-0.650(4.16%) |
Mkt cap ! $1.969B | |||
| Open | High | Low | Value | Volume |
| $15.65 | $15.72 | $14.90 | $3.146M | 206.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 91 | $14.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.99 | 239 | 3 |
View Market Depth
| Last trade - 11.26am 19/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |